Clinical Trials Browser

Withdrawn × OTHER × sipuleucel-T × Clear all

NCT02793219 2017-10-30

Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer

Phase 2 Withdrawn

Neoplasm Metastasis, Prostatic Neoplasms

NCT02793765 2017-10-30

Docetaxel Followed by Provenge in Metastatic Prostate Cancer

Phase 2 Withdrawn

Neoplasm Metastasis, Prostatic Neoplasms